Blog - Consumer Justice Foundation

Our Blog

Major Elmiron Warning Label Update Highlights Risk of Retinal Damage Side Effects

June 23, 2020

Significant new safety warnings have been added to the label for Elmiron, a medication commonly prescribed to treat pain and discomfort associated with a bladder condition called interstitial cystitis (IC). On June 16, 2020, for the first time since Elmiron’s introduction in 1996, manufacturer Janssen Pharmaceuticals warned… Read More> Comments Off on Major Elmiron Warning Label Update Highlights Risk of Retinal Damage Side Effects

Family Sues Zantac Makers Over Fatal Case of Pancreatic Cancer

June 4, 2020

The surviving family member of a Pennsylvania man who died from pancreatic cancer last year has filed a wrongful death lawsuit against the makers of Zantac, alleging that years of exposure to carcinogenic chemicals in the recalled heartburn drug caused her loved one’s death. The Zantac wrongful… Read More> Comments Off on Family Sues Zantac Makers Over Fatal Case of Pancreatic Cancer

J&J Discontinues Talc-Based Baby Powder Amid Nearly 20,000 Cancer Claims

May 22, 2020

Faced with nearly 20,000 lawsuits involving talcum powder cancer claims, Johnson & Johnson announced this week that it will no longer sell talc-based Baby Powder, a product that has been a hallmark of the company for more than a century. Since 1894, Johnson & Johnson has marketed… Read More> Comments Off on J&J Discontinues Talc-Based Baby Powder Amid Nearly 20,000 Cancer Claims

Federal Judge Assigns More Than Two Dozen Attorneys to Leadership Positions in Zantac Cancer MDL

May 14, 2020

The federal judge overseeing the Zantac multidistrict litigation (MDL) has chosen more than two dozen plaintiffs’ attorneys to serve in leadership positions in the growing litigation over the recalled heartburn drug Zantac and its potential to cause cancer in users. After interviewing 62 attorneys involved in the… Read More> Comments Off on Federal Judge Assigns More Than Two Dozen Attorneys to Leadership Positions in Zantac Cancer MDL

Appeals Court Reinstates Risperdal Gynecomastia Claims Against Johnson & Johnson

May 13, 2020

A California appeals court has reinstated the eligibility of thousands of cases against Johnson & Johnson and its Janssen Pharmaceuticals subsidiary, alleging that the company’s antipsychotic drug Risperdal causes abnormal breast growth in males. The court ruling reverses a lower court’s decision to grant Johnson & Johnson’s… Read More> Comments Off on Appeals Court Reinstates Risperdal Gynecomastia Claims Against Johnson & Johnson

Daubert Ruling Green Lights 16,000 Talcum Powder Cases Against Johnson & Johnson

May 12, 2020

A recent ruling from a federal judge in New Jersey has cleared the way for thousands of talcum powder cancer lawsuits against Johnson & Johnson to proceed. The ruling, handed down by U.S. District Judge Freda L. Wolfson, allows testimony from plaintiffs’ medical and scientific experts, including… Read More> Comments Off on Daubert Ruling Green Lights 16,000 Talcum Powder Cases Against Johnson & Johnson

Start Claim Now
Do you deserve compensation?

An attorney will review your situation for FREE and help you found out what really went wrong.

How Can We Reach You?

Please Explain Your Situation

By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.
×